Pfg Advisors Gilead Sciences, Inc. Transaction History

Pfg Advisors

$3 Billion
Q2 2025

A detailed history of Pfg Advisors transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pfg Advisors holds 5,844 shares of GILD stock, worth $701,396. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,844

Previous 3,945 48.14%

Holding current value

$701,396

Previous $442,000 46.38%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$96.91 - $113.0 $184,032 - $214,587	1,899 Added 48.14%	5,844 $647,000
Q1 2025 May 05, 2025	SELL	$89.14 - $117.41 $5,704 - $7,514	-64 Reduced 1.6%	3,945 $442,000
Q4 2024 Feb 07, 2025	SELL	$83.95 - $97.9 $4,365 - $5,090	-52 Reduced 1.28%	4,009 $370,000
Q3 2024 Oct 15, 2024	SELL	$66.59 - $83.99 $5,926 - $7,475	-89 Reduced 2.14%	4,061 $340,000
Q2 2024 Aug 07, 2024	BUY	$63.15 - $72.88 $71,801 - $82,864	1,137 Added 37.74%	4,150 $284,000
Q1 2024 May 06, 2024	SELL	$71.58 - $87.29 $18,610 - $22,695	-260 Reduced 7.94%	3,013 $220,000
Q4 2023 Jan 19, 2024	SELL	$73.27 - $83.09 $6,447 - $7,311	-88 Reduced 2.62%	3,273 $265,000
Q3 2023 Oct 13, 2023	BUY	$73.94 - $80.67 $48,208 - $52,596	652 Added 24.07%	3,361 $251,000
Q2 2023 Jul 20, 2023	BUY	$76.01 - $86.7 $988 - $1,127	13 Added 0.48%	2,709 $208,000
Q1 2023 Apr 20, 2023	BUY	$77.31 - $88.08 $7,189 - $8,191	93 Added 3.57%	2,696 $223,000
Q4 2022 Jan 27, 2023	BUY	$62.32 - $89.47 $162,218 - $232,890	2,603 New	2,603 $223,000
Q3 2020 Oct 13, 2020	SELL	$62.1 - $78.08 $406,134 - $510,643	-6,540 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $12,659 - $14,700	175 Added 2.75%	6,540 $499,000
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $4,822 - $6,176	-77 Reduced 1.2%	6,365 $517,000
Q4 2019 Jan 14, 2020	BUY	$61.62 - $67.78 $8,010 - $8,811	130 Added 2.06%	6,442 $424,000
Q3 2019 Oct 15, 2019	SELL	$62.51 - $69.0 $4,688 - $5,175	-75 Reduced 1.17%	6,312 $391,000
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $12,374 - $13,876	-200 Reduced 3.04%	6,387 $427,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $35,266 - $39,508	-564 Reduced 7.89%	6,587 $428,000
Q4 2018 Feb 19, 2019	BUY	$60.54 - $79.0 $20,523 - $26,781	339 Added 4.98%	7,151 $468,000
Q4 2018 Jan 18, 2019	BUY	$60.54 - $79.0 $412,398 - $538,148	6,812 New	6,812 $463,000

Others Institutions Holding GILD

# of Institutions

2,298

Shares Held

Call Options Held

9.42M

Put Options Held

9.72M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $150B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Advisors with notifications on news.

Account